These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of the potentiating effects of nicorandil and its denitrated metabolite (SG-86) on the adenosine-induced vasodepression in rats. Sakai K, Saito K. Fundam Clin Pharmacol; 1998; 12(5):492-7. PubMed ID: 9794146 [Abstract] [Full Text] [Related]
5. Analysis of pulmonary and systemic vascular responses to cromakalim, an activator of K+ATP channels. Minkes RK, Kvamme P, Higuera TR, Nossaman BD, Kadowitz PJ. Am J Physiol; 1991 Mar; 260(3 Pt 2):H957-66. PubMed ID: 1825747 [Abstract] [Full Text] [Related]
7. Synergistic effect of calcitonin gene-related peptide on adenosine-induced vasodepression in rats. Sakai K, Saito K, Akima M. Eur J Pharmacol; 1998 Mar 05; 344(2-3):153-9. PubMed ID: 9600650 [Abstract] [Full Text] [Related]
8. Nicorandil, its denitrated metabolite, SG-86 and naturally occurring vasodilators synergistically interact on adenosine-induced vasodepression in rats: special reference to adrenomedullin. Sakai K, Saito K. Fundam Clin Pharmacol; 1999 Mar 05; 13(1):27-33. PubMed ID: 10027085 [Abstract] [Full Text] [Related]
9. Spasmolytic action of nicorandil in canine conductive coronary arteries in vivo is not modified by glibenclamide. Imagawa J, Akima M, Nabata H, Taira N. J Cardiovasc Pharmacol; 1992 Jan 05; 19(1):108-14. PubMed ID: 1375676 [Abstract] [Full Text] [Related]
10. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo. Kamijo T, Iwai T, Haruta K, Takeda K. Arch Int Pharmacodyn Ther; 1996 Jan 05; 331(3):273-84. PubMed ID: 9124999 [Abstract] [Full Text] [Related]
11. The dualistic mode of action of the vasodilator drug, nicorandil, differentiated by glibenclamide in 86Rb flux studies in rabbit isolated vascular smooth muscle. Kreye VA, Lenz T, Theiss U. Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan 05; 343(1):70-5. PubMed ID: 1827659 [Abstract] [Full Text] [Related]
12. Effects of ATP-sensitive K+ channel openers on pacemaker activity in isolated single rabbit sino-atrial node cells. Satoh H. J Cardiovasc Pharmacol; 1993 Dec 05; 22(6):863-8. PubMed ID: 7509906 [Abstract] [Full Text] [Related]
13. K+ channel opening mediates the vasorelaxant effects of nicorandil in the intact vascular system. Cavero I, Pratz J, Mondot S. Z Kardiol; 1991 Dec 05; 80 Suppl 7():35-41. PubMed ID: 1838848 [Abstract] [Full Text] [Related]
14. Analysis of relaxation and repolarization mechanisms of nicorandil in rat mesenteric artery. Fujiwara T, Angus JA. Br J Pharmacol; 1996 Dec 05; 119(8):1549-56. PubMed ID: 8982500 [Abstract] [Full Text] [Related]
15. Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil. Yanagisawa T, Teshigawara T, Taira N. Br J Pharmacol; 1990 Sep 05; 101(1):157-65. PubMed ID: 2149290 [Abstract] [Full Text] [Related]
16. Endothelin-1 partially inhibits ATP-sensitive K+ current in guinea pig ventricular cells. Kobayashi S, Nakaya H, Takizawa T, Hara Y, Kimura S, Saito T, Masuda Y. J Cardiovasc Pharmacol; 1996 Jan 05; 27(1):12-9. PubMed ID: 8656645 [Abstract] [Full Text] [Related]
17. Nicorandil as a nitrate, and cromakalim as a potassium channel opener, dilate isolated porcine large coronary arteries in an agonist-nonselective manner. Satoh K, Mori T, Yamada H, Taira N. Cardiovasc Drugs Ther; 1993 Aug 05; 7(4):691-9. PubMed ID: 8241013 [Abstract] [Full Text] [Related]
18. Pharmacological properties of ATP-sensitive K+ channels in mammalian skeletal muscle cells. Allard B, Lazdunski M. Eur J Pharmacol; 1993 Jun 04; 236(3):419-26. PubMed ID: 8359200 [Abstract] [Full Text] [Related]
19. Differential effects of nicorandil on the vasodepressor responses to vasoactive polypeptides administered intravenously to rats. Sakai K, Akima M, Saito K. J Pharm Pharmacol; 1998 Feb 04; 50(2):211-4. PubMed ID: 9530990 [Abstract] [Full Text] [Related]
20. Specific antagonism by glibenclamide of negative inotropic effects of potassium channel openers in canine atrial muscle. Satoh E, Yanagisawa T, Taira N. Jpn J Pharmacol; 1990 Oct 04; 54(2):133-41. PubMed ID: 2150209 [Abstract] [Full Text] [Related] Page: [Next] [New Search]